Revenue Recognition - Disaggregation of Revenue (Details) - Revenue from Contract with Customer Benchmark - Product Concentration Risk	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Cell Engineering Revenue [Member]
Disaggregation of Revenue [Line Items]
Concentration risk	100.00%	100.00%
Pharmaceutical and biotechnology
Disaggregation of Revenue [Line Items]
Concentration risk	31.00%	28.00%
Agriculture
Disaggregation of Revenue [Line Items]
Concentration risk	41.00%	28.00%
Food and nutrition
Disaggregation of Revenue [Line Items]
Concentration risk	4.00%	17.00%
Government and defense
Disaggregation of Revenue [Line Items]
Concentration risk	16.00%	16.00%
Industrial and environment
Disaggregation of Revenue [Line Items]
Concentration risk	7.00%	10.00%
Consumer and technology
Disaggregation of Revenue [Line Items]
Concentration risk	1.00%	1.00%